Skip to content

Effect of strength training combined with physiotherapeutic exercises on muscle recovery and rehabilitation in athletes and active adults: an evaluation of the heart, muscle, and blood: a randomized placebo-controlled trial

Effect of strength training combined with different therapeutic modalities on musculoskeletal mecovery and rehabilitation in athletes and recreationally active adults: an integrated approach to cardiovascular, autonomic, neuromuscular, and blood responses: a randomized placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-47274gx
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Interventions

This is a randomized, placebo-controlled clinical trial in which the sample will be allocated using a random numbers table into three intervention groups over 8 weeks, with each technique being added
E02.760.169.063.500.387.875

Sponsors

Sociedade Unificada Augusto Motta
Lead Sponsor
Sociedade Unificada Augusto Motta
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Perform at least 300 minutes of physical activity per week. Be between 18 and 59 years old. Both sexes. Be free from functional limitations that prevent the tests and/or the proposed protocol from being performed.

Exclusion criteria

Exclusion criteria: Consuming caffeine-based ergogenic aids. Reporting any type of acute dizziness. Presenting abnormal fluid accumulation (edema), especially in the lower limbs. Presenting impairments in the basilar artery that make cervical manipulations impossible. Diagnoses that affect postural control, such as vestibular dysfunction, Alzheimer's disease, Parkinson's disease, or motor neuron disorders. History of lower limb trauma in the last year. Presence of severe cardiopulmonary disease. Participants currently involved in a structured exercise program focused on postural control.

Design outcomes

Primary

MeasureTime frame
An increase in lower limb muscle strength is expected, as assessed by the 1RM test, evidenced by a variation of at least 5% between pre- and post-intervention measurements.;A reduction in iR-R intervals and regulation of the sympathovagal balance are expected, as assessed by heart rate variability analysis, evidenced by a variation of at least 5% between pre- and post-intervention measurements.;A reduction in blood pressure is expected, as assessed by oscillometric analysis, evidenced by a variation of at least 5% between pre- and post-intervention measurements;;A reduction in blood inflammatory levels is expected, as assessed by blood analysis of IL-6, TNF-a, and C-reactive protein, evidenced by a variation of at least 5% between pre- and post-intervention measurements.;A reduction in muscle stress levels is expected, as assessed by blood analysis of CK and lactate, evidenced by a variation of at least 5% between pre- and post-intervention measurements.

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactEstêvão Monteiro

Centro Universitário Augusto Motta

profestevaomonteiro@gmail.com+55(21)38829702

Outcome results

None listed

Source: REBEC (via WHO ICTRP)